SP 50/500 MG TABLET

Product Description

Product Name: SP 50/500 MG TABLET
Composition: Sitagliptin 50mg + Metformin 500mg

Product Description for Trade India & B2B Platforms:

SP 50/500 MG TABLET is a clinically proven combination of Sitagliptin 50mg and Metformin 500mg, formulated to manage Type 2 Diabetes Mellitus effectively. This dual-action oral antidiabetic helps improve glycemic control by enhancing insulin sensitivity and stimulating insulin secretion. Widely trusted by healthcare professionals, SP 50/500 MG is ideal for pharmaceutical wholesalers, retailers, and bulk buyers looking to stock a high-demand diabetes care solution.

Key Benefits:

• Complementary Mechanism of Action: Sitagliptin (DPP-4 inhibitor) increases insulin release, while Metformin (biguanide) reduces hepatic glucose production.

• Effective HbA1c Reduction: Enhances long-term blood sugar management.

• Well-Tolerated Dosage: 500mg Metformin dose minimizes GI discomfort while maintaining efficacy.

• Convenient Oral Therapy: Suitable for once or twice-daily dosing with meals.

Usage/Application:

• Used in adults with Type 2 Diabetes when monotherapy fails to provide adequate glycemic control.

• Often prescribed as a first-line combination therapy.

• To be administered under the guidance of a qualified healthcare professional.

Why Choose SP 50/500 MG:

• Balanced formulation for beginner and maintenance diabetes therapy.

• Manufactured in WHO-GMP certified facilities with strict quality standards.

• Available in bulk packs with private labeling options for distributors.

• Competitive pricing and high demand across diabetic care segments.